Oxidative stress enhances and modulates protein S
-nitrosation in smooth muscle cells exposed to S -nitrosoglutathione 
Introduction
Cardiovascular diseases like atherosclerosis, pulmonary hypertension, thrombosis, ischemia and cardiac arrhythmia are usually associated with oxidative stress and a reduced bioavailability of nitric oxide (NO) [1] . To overcome this aspect, several NO-related therapeutics have emerged over the past few decades, such as nitrosamines [2] , organic nitrates [3] , and N-diazeniumdiolates [4] . However, these compounds induce undesirable effects, such as tolerance and hypotension, and are often considered as oxidative stress enhancers in an environment rich in oxygen and/or radical species, where they may favour the formation of peroxynitrite ions (ONOO -), a reactive nitrogen species (RNS) producing deleterious protein nitration [5, 6, 7, 8] . Other NO coumpounds, such as S-nitrosothiols may represent safer alternatives [9, 10] . Several investigations on the therapeutic potential of Snitrosothiols have focused on S-nitrosoglutathione (GSNO), the physiological storage form of NO in tissues, due to the absence of recorded side effects in preclinical studies [11, 12, 13] .
However, even though S-nitrosothiols are not prooxidant per se, the ability of GSNO to regulate NO bioavailability under oxidative stress conditions has not yet received sufficient attention.
Oxidative stress in the vessel wall has been shown to involve the tunica media, where smooth muscle cells (SMC) can produce reactive oxygen species (ROS) -e.g. superoxide anion, O2 •--following the activation of their own NADPH oxidase. SMC probably represent a privileged target of ROS [14] . Exposure of SMC cells to ROS-generating systems actually stimulates migration, proliferation, and growth [15, 16, 17, 18] . SMC also are a main target of (endothelium-derived or exogenous) NO, which exerts in this way its vasorelaxing effects.
NO, besides its direct role in vascular function, also participates in redox signaling by modifying proteins via S-nitrosation. The S-nitrosation, which is the formation of a covalent bond between NO and the sulfhydryl group of a cysteine residue, is a redox dependent, thiol-based, reversible posttranslational modification of proteins [19, 20, 21] . There are emerging data suggesting that S-nitrosation of proteins plays an important role both in physiology and in a broad spectrum of pathologies [22] . Pathophysiology correlates with hypo or hyper Snitrosation level of specific protein targets. This dysregulation of protein S-nitrosation results from a modification of NO availability (quantity and/or localization). NO availability results not only from alterations of the expression, compartmentalization and/or activity of NO synthases, but also reflects the contribution of denitrosylases, including GSNO-metabolizing enzymes, like GSNO reductase releasing GSNHOH, a non active NO-related molecule, and the gamma-glutamyltransferase (GGT) releasing cys-gly-NO, an active NO-related molecule [23] . Redoxines like protein disulfide isomerase (PDI) known to reverse thiol oxidation can also catabolise GSNO to release NO [24] .
In the present study, we aimed to assess the suitability and potency of GSNO as a NO donor in an oxidative stress environment. Its metabolism by two specific redox enzymes (GGT and PDI), the cellular thiol redox status and protein S-nitrosation were thus analyzed in SMC exposed to oxidative stress induced by a free radical generator, i.e. 2,2'-azobis(2amidinopropane) dihydrochloride (AAPH). We more specifically evaluated whether oxidative stress modulates the bioactivity of GSNO, by favouring release of NO and S-nitrosation of potentially critical protein targets related with cell contraction, morphogenesis and movement.
Materials and methods

Materials
Chemicals
All reagents were of analytical grade and all solutions prepared with ultrapure deionized water (>18.2 mΩ.cm). The Bicinchoninic acid (BCA) protein assay kit was purchased from Pierce and protease inhibitor cocktail from Roche. The N- [6- (biotinamido)hexyl]-3'-(2'-pyridyldithio)-propionamide biotin (Ez-Link Biotin-HPDP) and the high capacity neutravidin agarose resin were obtained from Fisher Scientific. All other reagents came from Sigma, France, country not precised for other companies.
Synthesis of S-nitrosoglutathione
GSNO was synthesized as previously described [25] . Briefly, reduced glutathione (GSH) was incubated with an equivalent amount of sodium nitrite under acidic conditions (0.626 M HCl). The concentration of GSNO was calculated using the specific molar absorbance of S-NO bond at 334 nm (ε = 922 M -1 cm -1 ) and the Beer-Lambert law. . Finally, the diazonium salt formed was made to react with 10 µL of a 0.6% (w/v) N-
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(1-naphthyl) ethylenediamine solution to form a chromophoric azo product that absorbs at 540 nm. To calculate the concentration of S-nitrosothiols, free nitrite ions quantified by Griess assay were subtracted from those obtained with the Griess-Saville assay.
Quantification of intracellular S-nitrosothiols
Intracellular S-nitrosothiols were quantified by using the 2,3-diaminonaphthalene (DAN) fluorogenic probe (this assay offers a lower limit of quantification than the Griess method). After incubation (see section 2.2.), cells were washed with PBS and lysed with 500 µL of 0.4% (w/v) Triton X-100 in 0.1 M HCl. The intracellular S-nitrosated proteins were quantified by the DAN (nitrite ions) or DAN-Hg 2+ (S-nitrosothiols) assays using standard curves (0.1 -1 µM) of sodium nitrite and GSNO, respectively [27] . The concentration of nitrite ions (DAN assay) was subtracted from the DAN-Hg 2+ quantification to obtain the intracellular S-nitrosothiols concentration, which was normalized upon the intracellular protein concentration (see section 2.7).
Thiol redox status
The redox potential of the culture medium was measured by using a redox electrode (Hanna Instruments) combined with a reference Ag/AgCl electrode (E = +0.207 V).
Quantification of reduced membrane thiols
After incubation, media were withdrawn and cells washed twice (PBS). Cells were then incubated for 10 min in the dark with 750 µL of 1 mM 5 
Quantification of intracellular reduced glutathione
Intracellular GSH was measured as previously described [28, 29] 
Quantification of intracellular protein reduced thiols
Intracellular protein reduced thiols were quantified using the DTNB method. After treatments, cells were lysed in a 3.3% (v/v) cold perchloric acid solution and centrifuged for 15 min at 10,000 × g. The pellets were resuspended in PBS containing 0.5% (V/V) sodium dodecylsulfate (SDS) and the resulting suspensions were incubated for 10 min in the dark after adding 700 µL of 1 mM DTNB. Then, 200 µL of each suspension were transferred in triplicate into a 96-wells microplate and the absorbance was read at 405 nm. Intracellular thiol concentrations were calculated using a GSH standard curve ranging from 3.25 µM to 32.5 µM and expressed relatively to protein content (see section 2.7).
Determination of gamma-glutamyltransferase activity
Gamma-glutamyltransferase activity was kinetically determined using the synthetic 
Total protein quantification
Protein determination was performed using the Pierce BCA Protein Assay Kit, following instructions of the manufacturer. A standard curve ranging from 0.025 to 1 mg.mL -1 was built with bovine serum albumin to calculate protein concentration.
Purification and identification of S-nitrosated cysteine residues in proteins
Cells incubated in a-75 cm 2 flask were lysed in 500 µL of 50 mM Tris (pH= 6.8)
neocuproine and protease inhibitor cocktail. S-nitrosated proteins were purified by the biotin switch technique as previously described [30, 31] , with some adaptations. Briefly, free thiols analyzed through label-free liquid chromatography coupled to matrix-assisted laser desorption/ionization (LC-MALDI) as previously described [32] . Proteins and peptides were identified based on fragmentation spectra by interrogation of the whole Swissprot database through the public Mascot server (taking in account protein scores above 80.0 and peptide scores above 50.0 at first rank, allowing one trypsin miscleavage and considering cysteine carbamidomethylation and methionine oxidation as optional). Finally, identified proteins were classified using the Panther database [33] .
Statistical analysis of data
Results are expressed as means ± standard error of the mean (sem). Statistical analyses were performed using either the Student t-test (for enzyme activity/expression or inhibition) or twoway ANOVA (pconditionbasal versus AAPH, ptreatmentwith or without GSNO and pinteraction between condition and treatment) followed by a Bonferroni's multiple comparisons test. The GraphPad Prism software (GraphPad Software version 5.0, San Diego, USA) was used.
Results
Validation of oxidative stress and S-nitrosation parameters of the cell model
The concentration of AAPH and GSNO used within this study were chosen upon the measurement of intracellular GSH concentration and intracellular formation of Snitrosothiols, respectively ( Fig. 1) . A 2-h incubation period of SMC in the presence of 50 mM AAPH significantly decreased (two times compared to the basal condition) the intracellular concentration of GSH without altering cell viability (90 ± 2 % using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye, MTT test) ( Fig. 1-A) . The GSNO concentration was fixed at 50 µM as the first effective concentration inducing significant intracellular S-nitrosothiols formation after a 1-h contact compared to basal condition ( Fig. 1-B ). Representative images showed a weak expression of PDI at cell plasma membrane under basal condition ( Fig. 2-A) and a small but proven increase of PDI expression under oxidative stress ( Fig. 2-B) . These images showed about 10% of cells expressing PDI at their plasma membrane under oxidative stress ( Fig. 2-B ) So, the present study explored the impact of GSNO incubated for a 1-h period after a 2-h period of oxidative stress induction leading to a total of 3-h of incubation. The intracellular GSH content significantly decreased with oxidative stress (Fig. 3 
Oxidative stress biomarkers
while extracellular GSH increased ( Fig. 3-B ) (pcondition < 0.0001 for both). The addition of GSNO very slightly (1.9 %) but significantly increase the extracellular GSH (ptreatment = 0.0395), both in basal and oxidative conditions (pinteraction ns), while did not allow the recovery of intracellular GSH level, which remained at a low value under AAPH exposure (ptreatment and pinteraction ns, Fig. 3-A) .
Reduced thiols at the plasma membrane (0.015 ± 0.002 nmol/µg of proteins) did not change with oxidative stress. Intracellular protein thiols decreased with oxidative stress in the absence of GSNO, while the addition of GSNO almost doubled the intracellular protein thiol content under oxidative stress (pinteraction< 0.0007, Fig. 3-C) . 
Extracellular GSNO metabolism and intracellular formation of S-nitrosothiols.
After 1-h contact with cells, only ca. 20 µM of GSNO ( Fig. 4-A) -out of the 50 µM initially added, and ca. 12 µM of nitrite ions ( Fig. 4-B) were measured in the extracellular space, indicating that GSNO is partly metabolized by SMC to release NO (detected as nitrite ions). 
Identification of S-nitrosated proteins
Purification and identification of proteins undergoing S-nitrosation revealed that 68 proteins were nitrosated under basal conditions, whereas 83 were S-nitrosated under oxidative stress. GSNO-nitrosated proteins were mainly present in cell compartments entitled cell part including cytosol, cell junction proteins and nucleus, organelle and macromolecular complexes both under basal and oxidative stress conditions (Table 1 ). The identified proteins belonged to 18 different classes for both conditions. However, a class of transporter proteins is only represented under basal condition, and a class of lyase is only represented under oxidative stress (Fig. 6 ). under oxidative stress. Such proteins are structural constituents of cytoskeleton variably implicated in muscle contraction, as well as in cell morphogenesis and movement (Table 2 ). are S-nitrosated on the same cysteine residue under basal or oxidative stress conditions ( Table   3 ). Others like elongation factor 1-gamma or filamin-C (FLN-C) showed supplementary cysteine residues S-nitrosated under oxidative stress or basal conditions, respectively.
However, S-nitrosated cysteine residues are at a different position within calponin-2 (CNN2) or alpha-actinin-1 following oxidative stress. As member of the same protein family, filamin-A (FLN-A) and FLN-C or transgelin (TAGLN) and transgelin-2 (TAGLN2) sequences were aligned to decipher whether their S-nitrosated cysteines were conserved residues along protein sequences. In FLN-A, the C53 (basal condition) and C810 (oxidative stress condition) Snitrosated residues are conserved cysteines numbered C47 and C806 in FLN-C sequence, respectively. Although, S-nitrosated C729 in FLN-C is conserved as C733 position in FLN-A sequence, this position is not S-nitrosated in FLN-A. All other identified S-nitrosated residues were non-conserved cysteines. In TAGLN and TAGLN2, only C38 is a conserved residue at the same place in the sequence of each protein. Finally, six proteins were found to be S-nitrosated exclusively under oxidative stress ( Table   4 ). Within the majority of these proteins, only one cysteine residue, upon 6 to 38 total cysteine residues for each protein, was affected by S-nitrosation. Pdz and lim domain protein 1 was the only protein showing two S-nitrosated cysteine residues over 8 total cysteine residues in its sequence. 
Discussion
The present study was designed to evaluate the bioactivity of GSNO in vascular SMC exposed to oxidative stress. Experiments were thus planned in order to assess the efficiency of GSNO-dependent NO release, and to verify possible quantitative/qualitative changes induced by oxidative conditions in cellular protein S-nitrosation.
From an experimental point of view, two main approaches can be used to induce oxidative stress, i.e. either by inhibiting cellular antioxidant defenses or by increasing the free radical load. The latter can be obtained by exposing cells to extracellular ROS like O2 •or H2O2. Prolonged enzymatic generation of O2 •can be sustained e.g. by the xanthine/xanthine oxidase system, which however can introduce a major bias in the results, as itself can denitrosate S-nitrosothiols [34] . H2O2 prooxidant effects are mediated by the formation of hydroxyl radical, • OH, through the transition metal-catalyzed Fenton reaction. However, transition metals are also known to catalyze direct degradation of S-nitrosothiols, preventing transition metals and H2O2 use in our study. On the other hand, the water soluble azocompound 2,2'-azobis(2-amidinopropane) dihydrochloride(AAPH) can be considered as a 'clean' and reproducible free radical generator, as one mole of AAPH spontaneously decomposes at 37°C into one mole of nitrogen and two moles of carbon-centered radicals.
AAPH-derived radicals can either combine with each other to produce a stable product, or react with molecular oxygen to generate peroxyl radicals (ROO • ), or with polyunsaturated lipids of cell membranes thus starting lipid peroxidation [35] . A number of studies have employed AAPH to investigate antioxidant defenses in cellular systems [36, 37] . More recently, cytotoxic and genotoxic effects of ROO • originating downstream of AAPH have been studied in a human microvascular endothelial cell line [38] . The effects of oxidative stress on the development of the cardiovascular system were also investigated after administration of AAPH in the air chamber of chicken embryos [39] . As far as SMC are concerned, AAPH was used (similar conditions to our study) to investigate the direct effects of free radicals on cyclic AMP-related cholesterol homeostasis [40] . On this background, the exposure of vascular SMC to AAPH was chosen as a simple and reproducible model of oxidative stress.
In our experiments, oxidative stress (in the absence of added GSNO) caused both a decrease in intracellular GSH and in SH groups of intracellular proteins, accompanied by an increase in extracellular GSH. The latter can be the result of AAPH-induced increase of GSH efflux as it was previously shown in erythrocytes challenged with H2O2, another oxidative stress inducer [41] . This increase in extracellular GSH concentration can be interpreted as a protection against the already known capacity of AAPH to directly oxidize plasma membrane proteins [42] . This speculation is confirmed in our work by the absence of variation of reduced thiol quantity at the plasma membrane of smooth muscle cells stress under AAPH challenge. GSH extracellular increase can also be due to the AAPH-induced decrease in GGT activity at the SMC plasma membrane level, which will lower the consumption of extracellular GSH. In fact, the AAPH-induced decrease of GGT activity can be explained as the effect of either direct inactivation of the enzyme protein by AAPH radicals or the large increase in the extracellular redox potential. Loss of cellular GGT activity was also reported following exposure of lung epithelial cells to hyperoxia-induced lipid peroxidation [43] , and indeed, AAPH is known to induce lipid peroxidation [44] .
Even if GGT activity is decreased by the AAPH-induced oxidative stress, the extracellular GSNO metabolism did not significantly change, as the consumption of added GSNO and the corresponding NO release were similar to basal conditions. In principle, the GSNO degradation might ensue from a direct oxidation by AAPH radicals. However, when checked in the absence of cells, the direct AAPH-mediated oxidation of GSNO (50 µM) actually released 4 ±0.1 µM nitrite ions, i.e. much less than the concentrations detected in the presence of SMC (18.3±0.6 µM), suggesting that most of the observed GSNO metabolism in oxidative stress conditions in SMC occurs through the activity of diverse cellular enzymes.
Oxidative stress increased the formation of intracellular S-nitrosothiols under GSNO addition, and GGT inhibition decreased it. GGT is a critical enzyme in GSNO metabolism [45] , essential for the release of NO and its subsequent utilization in S-nitrosothiols formation.
Here, we showed that, even if the GGT activity decreased under oxidative stress, it was still implicated in GSNO extracellular catabolism and intracellular S-nitrosothiols formation, in the same extent than under basal conditions. Actually, GGT inhibition did not entirely suppress GSNO metabolism, as it could not restore the initial extracellular concentration of GSNO: approx. 27 µM GSNO were detected at the end of the incubation with GGT inhibitor, vs 20 µM without inhibition and vs 50 µM initially added. Taken together, these findings indicate that GGT activity is certainly involved in the extracellular metabolism of GSNO, but other enzymes must also be implicated in this process. As regards with PDI, similar results were obtained: enzyme inhibition did not entirely suppress GSNO extracellular metabolism and approx. 28 µM GSNO (vs 20 µM without inhibition and 50 µM initially added) were detectable in the extracellular compartment at the end of incubation. Cellular GGT and PDI activities appear therefore to remain implicated in GSNO catabolism, even if they were inversely impacted by oxidative stress (GGT activity decreases, while PDI expression at the membrane level increases).
The observed increase in S-nitrosation of SMC proteins under oxidative stress conditions is rather unexpected, as prooxidants should oxidize reduced thiols to disulfides and/or other sulfur species, which may be then unavailable for S-nitrosation thus interfering with NO-based physiologic signaling [46] . Furthermore, in principle, the addition of GSNO in an oxidative stress environment would rather be expected to enhance oxidative stress by the production of peroxynitrite anions. However in our system, AAPH induces the production of intracellular peroxynitrite anion concentration (6.7 ± 0.8 µM, using dihydrorhodamine 123 probe), but the concomitant addition of GSNO did not modify this concentration (5.9 ± 0.4 µM). Moreover, it has been showed that S-nitrosation is a NO-protection from oxidation of thiols [47] .
This was confirmed, in our system, by the reversion of AAPH-induced decrease of protein -SH groups under GSNO condition. The protection offered by GSNO to intracellular protein -SH groups could be explained by the release of GSH concomitantly to the release of NO. Released GSH can be incorporated after digestion into the intracellular GSH pool to support GSH-dependent antioxidant defenses. However, our data did not show any recovery of intracellular GSH levels after GSNO addition, probably due to direct oxidation of GSH by AAPH challenge. Therefore, the ability of GSNO to protect reduced protein thiols from oxidative stress, making them again available to react with NO, may represent the mechanism explaining the increased formation of intracellular S-nitrosothiols observed under oxidative conditions.
Protein S-nitrosation is considered as an important mechanism for post-translational modulation of protein function, and several studies have described such modulatory effects on a series of cys-containing proteins, being potential targets of RNS-dependent nitrosative modifications [48] [49] [50] . In addition to direct modulation of protein function, protein Snitrosation can also represent a mean for constitution of a 'NO store' in tissues. Indeed, different studies support the idea that S-nitrosation of tissue thiols is a mechanism for the constitution of local reservoirs from which biologically active NO can be subsequently released [51] [52] [53] . Identification and assessment of such NO stores could provide a valuable biomarker for evaluation of the therapeutic efficiency of NO donors.
The increase in S-nitrosation mostly concerned proteins belonging to plasma membrane and extracellular region, which is not surprising considering that the AAPH- and Lipoma Preferred Partner (LPP). The role of S-nitrosation in regulating these proteins is not completely understood particularly during oxidative stress. Each of these proteins has been shown to play a role in regulating and modulating smooth muscle contraction or nitric oxide signaling. In vitro S-nitrosation of skeletal muscle myosin, for example, increases the force of the actomyosin interaction while decreasing its velocity indicating a relaxed state [54] . The calcium binding protein CNN2 has been shown to participate in regulating smooth muscle contraction by binding to actin, calmodulin, troponin C and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity [55, 56] . This tonic inhibition of the ATPase activity of myosin in smooth muscle is blocked by Ca 2+calmodulin, which inhibits CNN2 actin binding [57] . MRLCA regulates smooth muscle and non muscle cell contractile activity and it does bind calcium. TAGLN (also designated SM22α and p27) is a smooth muscle protein that physically associates with cytoskeletal actin filament bundles in contractile SMC. Studies in transgelin knockout mice have demonstrated a pivotal role for transgelin in the regulation of Ca 2+ independent contractility [58] and it is proposed to be necessary for actin polymerization and bundling [59] . Moreover, LPP, only found S-nitrosated under oxidative stress, is a nucleocytoplasmic shuttling protein, located in focal adhesions and associates with the actin cytoskeleton [60] . LPP can function as an adaptor protein that constitutes a platform that orchestrates protein-protein interactions and contributes to the migratory phenotype of SMC [61] . As ROS have also been shown to enhance cell migration [62, 63] and GSNO has been shown to decrease SMC migration capacity [64] , we can speculate that LPP S-nitrosation could protect against oxidative stress induced cell migration. Other proteins were also found S-nitrosated only under oxidative stress suggesting a difference of cysteine accessibility for NO under oxidative stress. This increase in cysteine accessibility can be managed under oxidative stress by redoxins like PDI and thioredoxin (Trx), whose activities are known to be increased under oxidative stress to reduce disulfide bounds formed by oxidant attacks. Furthermore, Trx activity was shown to be increased by GSNO [65] thus explaining the rise of intracellular thiols, which was found under GSNO added to our oxidative stress model. Indeed, our results showed an increase of PDI expression both at the plasma and organelle membranes level. Furthermore, PDI is known to catalyse transnitrosation reaction, so an increase in PDI activity by oxidative stress will probably lead to an increase in disulfide bound reduction and transnitrosation processes catalyzed by PDI. These extra S-nitrosated proteins included destrin, lim domain and actinbinding protein 1 (LIMA1) and talin-1 (TLN1). Destrin is a member of actin-binding family (ADF) proteins such as cofilin its isoprotein [66] . Destrin severs actin filaments (F-actin) and binds to actin monomers (G-actin) for actin depolymerization. It was shown that ADF family protein is responsible for F-actin dismantling through a redox-driven mechanism [67] . So, we can speculate that the S-nitrosation of destrin only under oxidative stress condition will interfere with actin filament severing through a redox mechanism. LIMA1 binds to actin monomers and filaments and inhibits actin filament depolymerization. LIMA1 expression was found significantly downregulated in cancers compared with normal tissues enhancing cancer cell invasion [68] . LIMA1 was also shown to be downregulated by oxidative stress [69] suggesting that the S-nitrosation observed only under oxidative stress in our experiments is a premise of a possible regulation of LIMA1 downregulation. Finally, TLN1 is involved in connections of major cytoskeletal structures to the plasma membrane. TLN1 is one of the major constituents with vinculin of focal adhesion contributing to cellular well-being and intercellular communication. It was found downregulated in instable atherosclerotic plaques [70] which opens speculation on its implication in tissue disintegration in atherosclerotic plaques driven by loss of interactions among cells of the extracellular matrix and remodeling of the tissue. As atherosclerosis is a context of oxidative stress and NO depletion, we can speculate that S-nitrosation of TLN1 found under oxidative stress could help to restore TLN-1 activity.
The identification of S-nitrosated cysteines showed different or same repartition within protein structure depending on proteins considered. Some cysteine residues were S-nitrosated in both conditions because they are the only cysteine within the protein structure, so cannot form an intraprotein disulfide bound. Furthermore, some proteins present an odd number of cysteine residues in their sequence, so the S-nitrosated one is probably never implicated in intraprotein disulfide bound formation. In some proteins like calponin-2 the S-nitrosated cysteine residues are at different positions within the protein sequence probably because of disulphide bound rearrangement during oxidative stress challenge. Filamin-C showed four cysteine residues S-nitrosated by GSNO under basal condition and only one under oxidative stress. It is possible that lost S-nitrosated cysteine residues were oxidized by AAPH challenge.
Therefore, considered together, all these proteins, almost quite implicated in Ca 2+dependent contractility, actin depolymerization and in NO signaling, constitute a potential interactome and discovering their behavior as S-nitrosated proteins may further help our understanding of several processes, such as contraction-relaxation signaling of SMC or their phenotype switching, in the vascular system.
In conclusion, our study documented that oxidative stress can significantly modify SMC metabolism of GSNO, an endogenous NO-donor presently under active investigation as a potential therapeutic agent. In particular, oxidative stress was shown to increase the extent, and deeply modify the pattern of GSNO-dependent protein S-nitrosation, with the additional involvement in the process of several proteins critical for SMC homeostasis and function.
These data can represent a valuable basis for the identification of biomarkers of GSNO bioactivity in the vascular system, as well as for the appraisal of possible beneficial effects of this NO donor in the treatment of CVD.
